HUMAN MADE Inc. (TYO:456A)
2,049.00
-91.00 (-4.25%)
Oct 7, 2026, 3:30 PM JST
HUMAN MADE Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 |
Cash & Equivalents | 10,409 | 9,973 | 5,709 | 3,880 |
Cash & Short-Term Investments | 10,409 | 9,973 | 5,709 | 3,880 |
Cash Growth | - | 74.69% | 47.14% | - |
Receivables | 1,245 | 663 | 367 | 296 |
Inventory | 1,116 | 1,058 | 767 | 709 |
Prepaid Expenses | - | 122 | 82 | 54 |
Other Current Assets | 613 | 393 | 248 | 74 |
Total Current Assets | 13,383 | 12,209 | 7,173 | 5,013 |
Property, Plant & Equipment | 2,249 | 1,011 | 390 | 341 |
Long-Term Investments | 1,133 | 894 | 390 | 129 |
Other Intangible Assets | 182 | 141 | 74 | 86 |
Long-Term Deferred Tax Assets | - | 258 | 214 | 140 |
Other Long-Term Assets | 1 | 1 | 2 | 2 |
Total Assets | 16,948 | 14,514 | 8,243 | 5,711 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 |
Accounts Payable | 644 | 529 | 345 | 403 |
Accrued Expenses | 125 | 273 | 116 | 102 |
Short-Term Debt | 50 | 50 | 279 | 50 |
Current Portion of Long-Term Debt | 133 | 199 | 39 | 67 |
Current Income Taxes Payable | 739 | 1,192 | 916 | 662 |
Current Unearned Revenue | - | 2 | 2 | 3 |
Other Current Liabilities | 1,163 | 327 | 359 | 356 |
Total Current Liabilities | 2,854 | 2,572 | 2,056 | 1,643 |
Long-Term Debt | - | 33 | - | 39 |
Other Long-Term Liabilities | 531 | 110 | 40 | 10 |
Total Liabilities | 3,385 | 2,715 | 2,096 | 1,692 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 |
Common Stock | 1,457 | 1,443 | 87 | 87 |
Additional Paid-In Capital | 1,497 | 1,483 | 128 | 128 |
Retained Earnings | 10,591 | 8,872 | 5,931 | 3,804 |
Comprehensive Income & Other | 18 | 1 | 1 | - |
Shareholders' Equity | 13,563 | 11,799 | 6,147 | 4,019 |
Total Liabilities & Equity | 16,948 | 14,514 | 8,243 | 5,711 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 |
Total Debt | 183 | 282 | 318 | 156 |
Net Cash (Debt) | 10,226 | 9,691 | 5,391 | 3,724 |
Net Cash Growth | - | 79.76% | 44.76% | - |
Net Cash Per Share | 398.70 | 427.02 | 61.32 | 46.54 |
Filing Date Shares Outstanding | 91.67 | 91.65 | 87.92 | 80.02 |
Total Common Shares Outstanding | 91.67 | 91.65 | 87.92 | 80.02 |
Working Capital | 10,529 | 9,637 | 5,117 | 3,370 |
Book Value Per Share | 147.96 | 128.75 | 69.92 | 50.22 |
Tangible Book Value | 13,381 | 11,658 | 6,073 | 3,933 |
Tangible Book Value Per Share | 145.98 | 127.21 | 69.07 | 49.15 |
Order Backlog | - | 821 | - | - |